α-difluoromethylornithine alters calcium signaling in platelet-derived growth factor-stimulated A172 brain tumor cells in culture

Burt G.F. Feuerstein, Jànos Szöllösi, Hirak S. Basu, Laurence J. Marton

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

α-Difluoromethylornithine (DFMO), an irreversible inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, inhibits the growth of brain tumor cell lines and is undergoing clinical trials as a treatment for brain tumors. Platelet-derived growth factor (PDGF) is thought to regulate the growth and development of precursors of both normal and neoplastic astrocytic cells; calcium signaling is thought to play a role in the transduction of PDGF signals. Using laser fluorescence image cytometry, flow cytometry, and spectrofluorometry, we studied the effect of DFMO on the calcium signals induced by PDGF in A172 human glioblastoma cells. Four days of treatment with 5 mM DFMO substantially shortened PDGF-induced calcium signals. The effect was reversed more than 10 h but less than 24 h after putrescine treatment, even though polyamines were repleted 4 h after putrescine and spermidine were added. DFMO did not substantially affect intracellular calcium release or the timing of the opening and closing of plasma membrane calcium channels. These findings support the notion that calcium signaling may be a target for inhibitors of polyamine metabolism.

Original languageEnglish (US)
Pages (from-to)6782-6789
Number of pages8
JournalCancer Research
Volume52
Issue number24
StatePublished - Dec 15 1992
Externally publishedYes

Fingerprint

Eflornithine
Calcium Signaling
Platelet-Derived Growth Factor
Brain Neoplasms
Polyamines
Cell Culture Techniques
Putrescine
Calcium
Image Cytometry
Ornithine Decarboxylase
Spermidine
Fluorescence Spectrometry
Calcium Channels
Glioblastoma
Tumor Cell Line
Ion Channels
Growth and Development
Flow Cytometry
Lasers
Fluorescence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

α-difluoromethylornithine alters calcium signaling in platelet-derived growth factor-stimulated A172 brain tumor cells in culture. / Feuerstein, Burt G.F.; Szöllösi, Jànos; Basu, Hirak S.; Marton, Laurence J.

In: Cancer Research, Vol. 52, No. 24, 15.12.1992, p. 6782-6789.

Research output: Contribution to journalArticle

@article{bd164c9ca0ab487ea16f4ebfc9aa92eb,
title = "α-difluoromethylornithine alters calcium signaling in platelet-derived growth factor-stimulated A172 brain tumor cells in culture",
abstract = "α-Difluoromethylornithine (DFMO), an irreversible inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, inhibits the growth of brain tumor cell lines and is undergoing clinical trials as a treatment for brain tumors. Platelet-derived growth factor (PDGF) is thought to regulate the growth and development of precursors of both normal and neoplastic astrocytic cells; calcium signaling is thought to play a role in the transduction of PDGF signals. Using laser fluorescence image cytometry, flow cytometry, and spectrofluorometry, we studied the effect of DFMO on the calcium signals induced by PDGF in A172 human glioblastoma cells. Four days of treatment with 5 mM DFMO substantially shortened PDGF-induced calcium signals. The effect was reversed more than 10 h but less than 24 h after putrescine treatment, even though polyamines were repleted 4 h after putrescine and spermidine were added. DFMO did not substantially affect intracellular calcium release or the timing of the opening and closing of plasma membrane calcium channels. These findings support the notion that calcium signaling may be a target for inhibitors of polyamine metabolism.",
author = "Feuerstein, {Burt G.F.} and J{\`a}nos Sz{\"o}ll{\"o}si and Basu, {Hirak S.} and Marton, {Laurence J.}",
year = "1992",
month = "12",
day = "15",
language = "English (US)",
volume = "52",
pages = "6782--6789",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - α-difluoromethylornithine alters calcium signaling in platelet-derived growth factor-stimulated A172 brain tumor cells in culture

AU - Feuerstein, Burt G.F.

AU - Szöllösi, Jànos

AU - Basu, Hirak S.

AU - Marton, Laurence J.

PY - 1992/12/15

Y1 - 1992/12/15

N2 - α-Difluoromethylornithine (DFMO), an irreversible inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, inhibits the growth of brain tumor cell lines and is undergoing clinical trials as a treatment for brain tumors. Platelet-derived growth factor (PDGF) is thought to regulate the growth and development of precursors of both normal and neoplastic astrocytic cells; calcium signaling is thought to play a role in the transduction of PDGF signals. Using laser fluorescence image cytometry, flow cytometry, and spectrofluorometry, we studied the effect of DFMO on the calcium signals induced by PDGF in A172 human glioblastoma cells. Four days of treatment with 5 mM DFMO substantially shortened PDGF-induced calcium signals. The effect was reversed more than 10 h but less than 24 h after putrescine treatment, even though polyamines were repleted 4 h after putrescine and spermidine were added. DFMO did not substantially affect intracellular calcium release or the timing of the opening and closing of plasma membrane calcium channels. These findings support the notion that calcium signaling may be a target for inhibitors of polyamine metabolism.

AB - α-Difluoromethylornithine (DFMO), an irreversible inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, inhibits the growth of brain tumor cell lines and is undergoing clinical trials as a treatment for brain tumors. Platelet-derived growth factor (PDGF) is thought to regulate the growth and development of precursors of both normal and neoplastic astrocytic cells; calcium signaling is thought to play a role in the transduction of PDGF signals. Using laser fluorescence image cytometry, flow cytometry, and spectrofluorometry, we studied the effect of DFMO on the calcium signals induced by PDGF in A172 human glioblastoma cells. Four days of treatment with 5 mM DFMO substantially shortened PDGF-induced calcium signals. The effect was reversed more than 10 h but less than 24 h after putrescine treatment, even though polyamines were repleted 4 h after putrescine and spermidine were added. DFMO did not substantially affect intracellular calcium release or the timing of the opening and closing of plasma membrane calcium channels. These findings support the notion that calcium signaling may be a target for inhibitors of polyamine metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0027071779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027071779&partnerID=8YFLogxK

M3 - Article

C2 - 1458466

AN - SCOPUS:0027071779

VL - 52

SP - 6782

EP - 6789

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 24

ER -